title: Whether the dissociation between toxicity and α-synuclein inclusion will be a possible therapy for Parkinson's disease or not?
authors.affiliation: Students'Scientific Research Center Tehran University of Medical Sciences Tehran, Iran.|Clinical Biochemistry Department School of Medicine Faculty of Medicine Tehran University of Medical Sciences Tehran, Iran.
authors.forename: Reyhane
authors.initials: R
authors.lastname: Ebrahimi
authors.affiliation: Students'Scientific Research Center Tehran University of Medical Sciences Tehran, Iran.|Basir Eye Health Research Center Tehran, Iran.
authors.forename: Soheila
authors.initials: S
authors.lastname: Sobhani
authors.affiliation: Basir Eye Health Research Center Tehran, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Abbastabar
mesh_terms: D006801:Humans; D002479:Inclusion Bodies; D010300:Parkinson Disease; D051844:alpha-Synuclein
chemical_list: D051844:alpha-Synuclein